Alacrita, a London-based consultancy to the pharmaceutical, biotechnology, and life science industries, is opening a small office in the Kendall Square, a Cambridge neighborhood that is a life sciences hotbed.
For the moment, Alacrita’s office is a one-person operation, but the hope is that it will quickly expand to 10 people, said Rob Johnson, the Alacrita partner now in Cambridge.
In a statement, Johnson added: “To date, we have concentrated on serving our European clients with their European needs. By expanding our presence to the heart of the world’s leading life science cluster, we are better configured to serve our growing roster of US clients with their consulting needs” said Johnson. “Massachusetts is home to more than 500 biotech and pharma companies with about 1,000 drugs in development.”
Alacrita’s decision to open a Cambridge office was announced by Massachusetts Life Sciences Center, the Massachusetts Office of International Trade & Investment, and MassBio.
The Massachusetts Life Sciences Center is a quasi-public agency of the Commonwealth of Massachusetts. According to its website, the center is the primary agency tasked with “realizing the vision” of Governor Deval Patrick’s life sciences initiative.
Alacrita’s announcement follows Patrick’s UK trade mission in March 2011, the center noted in its media advisory.